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Abstract Pronounced differences in the interactions of mono-
meric (lactone and carboxylate) and the J-type self-aggregated 
form of camptothecin (CPT), an inhibitor of DNA topoisomerase 
(topo) I, with human (HSA) and bovine (BSA) serum albumins 
were observed by using circular dichroism (CD) spectroscopy. 
HSA binding changes the geometry of the covalent structure of 
CPT due to hydrophobic contacts of the chromophore within the 
protein interior. The carbonyl group of the ring D of CPT (Fig. 
1A) interacts with the positively charged amino acid residues of 
HSA. Interaction with HSA induces disaggregation of the J-type 
self-aggregates of CPT. On the other hand, neither heat-
denatured HSA nor native BSA participated in binding of the 
lactone or carboxylate or self-aggregate forms of CPT. Analysis 
of HSA and BSA homology within the IIA and IIIA principle 
ligand-binding structural domains suggests that the binding site 
for the CPT chromophore is located in subdomain IIA. 
Hydrophobic contacts with Leu-203, Phe-211, and Ala-215 and 
electrostatic interactions with Lys-199 and/or Arg-222 of HSA 
may play a key role in formation of the drug-HSA complex. 
© 1997 Federation of European Biochemical Societies. 
Key words: Topoisomerase inhibitor; Circular dichroism; 
Camptothecin; Human serum albumin 
1. Introduction 
20(S)-Camptothecin (CPT), an alkaloid isolated from 
Camptotheca acuminata (Fig. 1A), and several of its recently 
synthesised derivatives have aroused considerable interest due 
to their ability to halt the growth of a wide range of human 
tumours [1]. The CPT family of drugs exhibits its cytotoxicity 
due to the inhibition of DNA topoisomerase I (topo I) by 
stabilising ternary DNA-drug-enzyme complexes, the so-
called cleavable complexes, and thus preventing the ligation 
step of the enzyme action [1,2]. The anticancer activity of 
CPTs is modulated by hydrolysis of the ring E a-hydroxy 5-
lactone moiety (Fig. 1A) under physiological conditions. A 
closed lactone ring is an important structural requirement 
both for passive diffusion of the drug into cancer cells and 
for successful interaction with the topo I target. A carboxylate 
form of CPT was found to be biologically non-active and even 
toxic. On the other hand, replacement of the 21-lactone 
(undergoing facile ring opening and closure reactions) by 
the 21-lactam (ring opening does not occur easily) also re-
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suited in the loss of activity [3]. This suggests that opening 
of the lactone ring may be an essential step in the mechanism 
of action of the drug: e.g. the ring-opened drug may form a 
reversible covalent bond with topo I via an ester exchange 
reaction, which might be facilitated by hydrogen bonding of 
the 20-hydroxyl to an electronegative atom on the enzyme [4]. 
Moreover, the interactions of CPTs within the cells and within 
the ternary complexes is stereospecific - the 20(,R)-CPT stereo-
isomer (Fig. 1A) is not active and does not trap ternary com-
plexes [4]. 
Factors influencing the structure and lactone-carboxylate 
equilibrium of CPTs are thus regarded as clearly important 
determinants of their function. Fluorescence studies show that 
the lactone and carboxylate forms of CPT bind HSA with 
different affinities: the ring-opened form (Fig. 1A) displays 
dramatic enhancement in its binding constant for HSA [5]. 
In contrast, red blood cells stabilise the biologically active 
form of CPT by allowing the lactone ring to partition into 
lipid bilayers, thereby protecting the moiety from hydrolysis 
[6]. Recent studies from our laboratories led to the discovery 
of a novel effect certainly influencing the biological activity of 
CPT and the derivatives: at low concentrations in aqueous 
buffer solutions, stable J-type aggregates are formed by the 
stacking interaction between the quinoline rings of the CPT 
chromophores with the inverse position of the nitrogen atoms 
[7]. Self-aggregation partially prevents hydrolysis of the lac-
tone ring at neutral pH values and J-aggregates were found to 
penetrate within the cells with much higher efficiency than the 
monomers of the drugs [8]. 
The drug effect is often correlated with the concentration of 
free or unbound drug in the blood or plasma. Thus, from 
both the pharmacokinetic and pharmacodynamic viewpoints, 
it is the free or unbound concentrations of CPT lactone in 
blood or plasma that can be used as predictive indicators of 
anticancer activity. HSA is a principle mediator of the trans-
port and metabolism of numerous ligands including pharma-
ceuticals. Binding to HSA may change the equilibrium be-
tween free and bound CPT, thus affecting the anticancer 
activity of the drug [9]. 
In this study, we have employed the circular dichroism 
(CD) approach in order to characterise the interactions of 
lactone, carboxylate, and self-aggregated forms of CPT with 
HSA and BSA. In contrast to fluorescence analysis, CD spec-
troscopy enables the detection of changes in the ground-state 
molecular conformation. Differences in CPT-HSA and CPT-
BSA interactions and analysis of the homology of the binding 
domains of two proteins allowed localisation of the binding 
site of CPT within HSA. J-aggregates of CPT were found to 
interconvert into the monomers in the presence of HSA but 
not when BSA was present. Interactions of CPT monomers 
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with HSA were supposed to include both hydrophobic con-
tacts (with the Leu-203, Phe-211, and Ala-215 residues of the 
IIA binding domain, Fig. IB) changing the geometry of the 
CPT structure and an interaction of the CPT carbonyl group 
of ring D and the carboxylate group of hydrolysed ring E 
(Fig. 1A) with charged (Lys-199 and/or Arg-222, Fig. IB) 
HSA amino acid residues. 
2. Materials and methods 
20(S)-CPT, crystallised HSA and BSA were purchased from Sigma. 
9NH2-CPT and the 20(R)-stereoisomer of CPT were supplied by the 
Drug Synthesis and Chemistry Branch, National Cancer Institute, 
Bethesda, MD. Drug stock solutions were made in DMSO (ACS 
spectrophotometric grade, Aldrich) at concentrations of 10, 1 or 0.1 
mM, and aliquots were stored in the dark at —70°C. Further dilutions 
were made in buffer (PBS) immediately before use and the corre-
sponding amounts of DMSO were adjusted to give the same 
DMSO concentration in all preparations. A 10 mM drug stock sol-
ution was used for preparation of the J-type self-aggregated form of 
CPT and a 1 mM stock solution was employed for the preparation of 
CPT monomers as described [7,8]. All other chemicals were of ana-
lytical-reagent grade and all solvents were of HPLC grade. 
CD spectra were measured using Jobin Yvon, Mark III and Jasco 
500C dichrographs. Protein and CPT concentrations were estimated 
from their molar absorption coefficients in PBS: e|J8 = 39 800 M_1 
cm-1 and e|™ = 19900 M_1 cm-1, respectively. UV-Vis spectra were 
recorded with a Philips PU 8720 UV-Vis scanning spectrophotometer. 
Experimental conditions are indicated in the figure legends. Measure-
ments were performed using quartz cells of 1, 0.1, 0.01, and 0.001 cm 
path length. The CD spectra were scaled to molecular ellipticity (Ae). 
3. Results and discussion 
3.1. General characteristics of CPT chromophore 
CPT includes two chromophores conjugated through ring C 
- rings AB (quinoline) and ring D with hydrolyzable ring E 
(Fig. 1 A). Ring E of CPT does not exert a strong influence on 
the electronic properties of the whole chromophore: upon 
hydrolysis, the UV-Vis spectra of the lactone and carboxylate 
forms of CPT are quite similar. Molecular modelling analysis 
shows that the molecule in solution is almost planar and ex-
hibits low ellipticity values in the corresponding CD spectra 
[7,8]. The optical activity of CPT is mediated by the asym-
metric carbon in position 20 of hydrolyzable ring E, and by 
the single out-of-plane nitrogen atom of ring C connected 
with the slightly out-of-plane carbonyl group of ring D [10]. 
The symmetry of each site strongly depends on the symmetry 
of the others. On going from the 20(5)-CPT to the 20(7?)-CPT 
isomer (Fig. 1A), the out-of-plane nitrogen atom of ring C 
changes its position from up to down relative to the plane of 
the chromophore [7]. This transformation induces inversion of 
the sign of the Cotton effect in the region 340-400 nm: 20(5)-
CPT exhibits a negative signal, whereas 20(7?)-CPT displays a 
positive CD signal. 
A closed lactone ring strengthens the covalent structure of 
the CPT chromophore and its hydrolysis leads to relaxation 
of the system and inversion of the position of the nitrogen 
atom in ring C relative to the plane of the chromophore 
molecule, similar to that induced by 20(R)-20(S)-C¥T isomer-
isation [8,10]. Hence, the CD spectra of CPT in solution 
should be extremely sensitive both to changes in geometry 
of the covalent structure of the chromophore and, conse-
quently, to the process of lactone ring hydrolysis accompanied 
by changes in the geometry of the CPT molecule. This phe-
nomenon may provide the possibility for sensitive on-line 
monitoring of drug interactions with the target as well as of 
the process of lactone hydrolysis in the presence of effectors. 
3.2. CD spectra of CPT monomers and kinetics of lactone 
hydrolysis followed by CD spectroscopy 
According to Clar's classification [11] all long-wavelength 
bands in the UV-Vis spectra of CPT are typical for quinoline 
(rings AB, Fig. 1A) but are shifted to the red as a result of 
conjugation of rings AB and D(E). For this type of conjugated 
and slightly twisted 7t-electron system, there are 9 main elec-
tronic transitions detectable in the UV-Vis and CD spectra. 
They include 3 transitions within the long-wavelength band 
lLa (approx. 380, 365, and 354 nm) and 6 others within the 
short-wavelength region [12]. In the case of the lLa band, the 
380 nm band exhibits the lowest rotational activity in the CD 
spectra whereas the two other show the highest values, how-
ever, the signs of all the CD bands are the same (Fig. 2A). 
The rotational activity (CD signals) for each transition reflects 
the extent to which the transition contributes to the phenom-
enon of optical activity. As a rule, all CD bands correspond-
ing to the same group of transitions (e.g. the bands at approx. 
380, 365, and 354 nm corresponding to the same lLa group) 
should have the same sign upon alterations induced by effects 
changing the molecular symmetry. Hydrolysis of the lactone 
ring changes the symmetry of the CPT molecule and induces 
inversion of the signs of the bands at 380, 365, and 354 nm 
(Fig. 2A). After hydrolysis the relative contribution of each of 
these bands to the optical activity is indeed changed as com-
pared with the lactone form, but simultaneous inversion of the 
sign for all three bands clearly confirms their attribution to 
the same n-n* transitions within the lLa band. 
The CD spectrum of the lactone form of CPT in the region 
300-340 nm shows another two bands with behaviour differ-
ent from that of the bands of the lLa group mentioned above. 
These bands (approx. 305 and 330 nm) do not change sign on 
going from the lactone to the carboxylate form of CPT (Fig. 
2A). The band at 305 nm is always positive and even remains 
unchanged in intensity upon hydrolysis, the band at 330 nm 
becoming smaller and totally disappearing on progressing 
from the lactone to the carboxylate form. The band at ap-
prox. 305 nm is probably attributable to the second (lLb) 
electronic transition of the 7i-electron system of CPT chromo-
phore [12]. Being very similar to the corresponding band of 
quinolines [13], this transition is essentially localised on rings 
AB which are less conjugated with the electron system of ring 
D(E). 
In contrast to the band at 305 nm, the band at 330 nm 
totally disappears after hydrolysis-induced relaxation of the 
structure of the 20(5)-CPT chromophore (Fig. 2A). This 
band, which is positive for the lactone form of 20(R)-CPT, 
also disappears upon hydrolysis of this isomer (data not 
shown). As noted above, reduced strength in the covalent 
structure of CPT leads to a symmetric configuration of the 
carbonyl group of ring D relative to the plane of chromo-
phore. In UV-Vis and CD spectra, the n-n* transition of the 
carbonyl group in aromatic ketones (structures corresponding 
to conjugated ring D of CPT) exhibits very similar bands at 
approx. 330 nm [12]. We assign the band at approx. 330 nm 
for CPT to the n-7i* transition of the carbonyl group of ring 
D. Hydrolysis-induced relaxation of the 20(5)-CPT (20(.R)-
CPT) structure leading to the lower- (upper-) plane transfer 
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Fig. 1. (A) Structures of lactone and carboxylate forms of 20(5)-CPT and its synthetic stereoisomer 20(R)-CPT. (B) Amino acid sequences of 
BSA and HSA in the regions of IIA and IIIA principle ligand-binding structural domains. Amino acid residues forming 3D structural ligand-
binding domains [17] are in bold-face. Amino acid residues forming 3D structural ligand-binding domains in HSA and replaced by others in 
BSA are in bold-face and encircled. Deletions in the primary structures correspond to the regions of total homology of the HSA and BSA. 
Panel B is modified from [16]. 
of the nitrogen of ring C places the carbonyl group of ring D 
in a symmetric position relative to the plane of the CPT chro-
mophore [8,10] and obviously may suppress the optical activ-
ity of the corresponding n-Ji* transition (Fig. 2A). 
3.3. Interaction of monomers of CPT with the HSA 
HSA binding induces three effects on the CD spectra of the 
CPT chromophore: (i) a pronounced effect of induced optical 
activity: the lactone form exhibits an approx. 3.5-fold increase 
and the carboxylate form an approx. 5-fold increase in molar 
ellipticity as compared with free CPT in solution; (ii) a long-
wavelength shift of the bands within the lLa electronic 
transition; and (iii) disappearance of the approx. 330 nm 
band for the lactone CPT-HSA complex and induction of 
this band for the carboxylate CPT-HSA complex (compare 
Fig. 2A,B). 
The theory of optical activity predicts that a chromophore 
of a low-molecular-weight ligand may become optically active 
or increase its internal optical activity as a result of two types 
of interactions: individual interactions of each chromophore 
with a macromolecule-asymmetric matrix (monomeric effect) 
or co-operative interactions between the ligands fixed on the 
matrix in close vicinity to each other (oligomeric effect) [14]. A 
characteristic feature of the oligomeric effect is its dependence 
on the ligand/matrix molar ratio. The CD spectra of CPT-
HSA complexes recorded at 1/1 and 1/5 molar ratios (data 
not shown) were found to be identical both in the levels of 
induced optical activities and in the relative ratios of the CD 
bands. Therefore, the chromophore-chromophore interaction 
was concluded to be small and the effect of the induced opti-
cal activity of the CPT chromophores should be determined 
by the 'monomeric' CPT interactions with the HSA asymmet-
ric matrix. Induced optical activity of the monomers in the 
region of the electronic transition of the molecule is deter-
mined by three factors: (i) asymmetrization electron rotation 
around the fixed nucleus; (ii) replacement of the equilibrium 
positions of the nucleus along the asymmetric normal coor-
dinates in the ground state; and (iii) the different character-




Fig. 2. (A) Hydrolysis kinetics (1-6) of the monomeric form of 
20(5)-CPT in PBS, pH 7.4. CD spectra were recorded in 10 min 
(1); 25 min (2); 40 min (3); 55 min (4); 150 min (5); 230 min (6). 
(B) Hydrolysis kinetics (2-8) of the monomeric form of 20(5)-CPT 
in complex with HSA in PBS buffer, pH 7.4. CD spectra were re-
corded in 10 min (2); 25 min (3); 40 min (4); 55 min (5); 70 min 
(6); 100 min (7); 230 min (8). Spectrum 1 (panel B) is the CD spec-
trum of 20(5)-CPT in DMSO solution. Scale for spectrum 1 is pre-
sented on the right-hand side. Concentration of 20(S)-CPT in all ex-
periments: 4xl0~5 M. Concentration of HSA: 4xl0~5 M. 
istics of asymmetrization of the molecule in the ground and 
excited states [15]. The first two effects induce CD with a form 
similar to that of the UV-Vis spectrum, i.e. without changes in 
the signs of the CD bands within the region of optically active 
electronic transitions. On the other hand, asymmetrization of 
the molecule in the ground and excited states induces splitting 
of the CD bands with changes in their signs, hence the forms 
of the CD and UV-Vis spectra become very different [14]. 
In our case, the CD bands of CPT-HSA complexes do not 
change sign within the ILa electronic transition but do exhibit 
a long-wavelength shift as compared with free CPT in aque-
ous buffer and exhibit the same position and profile as for 
CPT in non-polar DMSO solution (Fig. 2B). Hence, the ef-
fects of induced optical activity of CPT and changes in profile 
of the CD bands within the ILa transition in the presence of 
HSA is caused by replacement of the equilibrium positions of 
the nucleus along the asymmetric normal coordinates in the 
ground state (changes in the geometry of the molecule) due to 
the hydrophobic interactions. 
Asymmetrization of electron rotation around the fixed nu-
cleus should induce perturbations within the UV-Vis spectra 
accompanied by corresponding changes of the CD bands. 
This is the case for CPT derivatives with the charged groups 
introduced within or in close vicinity to the it-electron system 
of the chromophore [7,8]. On the other hand, changes in the 
geometry of the molecule do not induce pronounced changes 
in the UV-Vis spectra, whereas the corresponding CD spectra 
may be quite different. For example, hydrolysis of the lactone 
ring of free CPT does not induce strong changes in the UV-
Vis spectra (i.e. no strong redistribution of electron density 
within the chromophore) but leads to dramatic differences in 
the CD spectra (Fig. 2A, changes in the signs of CD bands). 
The UV-Vis spectra of CPT in the complex with HSA show 
slight modifications comparable with those on hydrolysis of 
the lactone ring. 
Interaction of the lactone form of CPT with HSA results in 
the disappearance of the optical activity of the 330 nm n-ir* 
carbonyl electronic transition (Fig. 2B). It should be noted 
that if hydrolysis of free lactone leads to the loss of optical 
activity of the n-7t* transition (Fig. 2A), then the interaction of 
the carboxylate form of CPT with HSA restores its optical 
activity (intense shoulder at approx. 330 nm, Fig. 2B). This 
reflects an interaction of the carbonyl of ring D of the carbox-
ylate form of CPT within the HSA moiety. Interaction of the 
carboxyl group of hydrolysed ring E with the charged groups 
of HSA may also contribute to the changes in CPT carbonyl 
symmetry. 
Hence, the monomeric effects of induced optical activity of 
CPT in the presence of HSA are caused by replacement of the 
equilibrium positions of the nucleus in the ground state, i.e. 
by deformations of the covalent structure of the molecule due 
to the hydrophobic contacts of CPT with HSA, and modifi-
cations within the 330 nm band may reflect interactions of the 
carbonyl group of ring D of the lactone form of CPT and 
interactions of the carbonyl group of ring D and the carboxyl 
group of hydrolysed ring E of the carboxylate form of CPT 
with the positively charged amino acid residues of the protein. 
3.4. Interactions of J-aggregates of CPT with HSA 
We have recently shown that some derivatives of the CPT 
family in aqueous buffer solution may form J-type aggregates 
[7,8]. These aggregates appear under certain dilution condi-
tions for stock DMSO solutions of 20(5)-CPT, 10,11-methyl-
enedioxy-CPT and 7-ethyl-10-hydroxy-CPT and are charac-
terised by very large CD signals with molar ellipticity values 
in range of 20^10 M - 1 cm- 1 . The aggregates were found to be 
stereospecific, being undetectable for the 20(.R)-stereoisomer 
of CPT and were formed by the stacking interaction between 
the quinoline rings of the CPT chromophores with the inverse 
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Fig. 3. (A) CD spectra of J-aggregates of 20(S)-CPT in complex with the HSA in PBS, pH 7.4, recorded immediately after mixing (1); in 10 
min (2), and in 24 h after mixing (3). (B) CD spectra of J-aggregates of 20(5)-CPT in complex with the BSA in PBS, pH 7.4, recorded immedi-
ately after mixing (1); in 10 min (2) and in 24 h after mixing (3). (C) CD spectra of monomers of 20(5)-CPT in PBS, pH 7.4, buffer solution 
(2) and in complex with the BSA (1). Concentration of 20(S)-CPT: 2x 10-5 M. Concentrations of HSA and BSA: 2x 10-4 M. 
position of the nitrogen atoms. The aggregates were found to 
penetrate within the cells with much higher efficiency and to 
exhibit much greater cytotoxic effects as compared with the 
monomeric form of the drugs [7,8]. In this paper, we have 
shown that addition of HSA to the aqueous buffer solution 
of self-aggregated CPT induces disaggregation of the drug 
which is detectable as a decrease in the corresponding CD 
signals (Fig. 3A). It is difficult to say whether, in the presence 
of HSA, the rate of hydrolysis of the lactone ring within the 
self-aggregated species is the same as for the monomers: it is 
not possible to detect the CD signals of the monomers on the 
background of the approx. 100-fold stronger bands of the 
aggregates. However, it is clear that the interaction of CPT 
chromophores with HSA is much stronger than the interchro-
mophores interaction within the aggregates. 
3.5. Interactions of CPT with denatured HSA and with native 
BSA 
Interactions of lactone, carboxylate or self-aggregated 
forms of CPT with HSA were found to be strongly affected 
by alterations of the native protein structure. Heat-denatured 
HSA used at the same concentrations as the native protein 
does not exert any effects on the CD spectra of free CPTs. 
Therefore, the effects described above were found to be spe-
cific. 
The CD spectra of CPT monomers do not exhibit effects of 
induced optical activity or changes in profile of the bands 
which are characteristic of the free monomeric CPT chromo-
phores in aqueous solution (Fig. 3C); also, the CD spectra of 
CPT J-aggregates do not exhibit effects of disaggregation (Fig. 
3B) in the presence of BSA. 
HSA and BSA are highly homologous proteins [16], espe-
cially within the structural domains responsible for the ligand-
protein interactions (Fig. IB, the so-called IIA and IIIA do-
mains [17]). Moreover, these ligand-binding domains in HSA 
and BSA are characterised by extremely high structural ho-
mology [18,19]. Hence, the disappearance of specific CPT/pro-
tein interactions in the presence of BSA compared with HSA 
provides us with the possibility of identifying individual ami-
no acid residues playing a key role in CPT/HSA interactions. 
Replacement of these residues by others in BSA as compared 
with HSA (Fig. IB) leads to the absence of CPT binding by 
BSA (Fig. 3B,C). 
It should be noted that crystallographic analysis of CPT-
HSA complexes is in progress [9] and the possibility of pre-
dicting the exact amino acid residues involved in the drug-
protein interactions may have a fundamental interest. 
The binding cavity in the IIIA domain of albumins is the 
most active and accommodating on HSA and BSA. Many 
ligands were found to bind preferentially at this location, 
for example, digitoxin, ibuprofen and tryptophan [17]. Aspirin 
and iodinated aspirin analogues show nearly equal distribu-
tion between binding sites located in IIA and IIIA. Warfarin 
occupies a single site in IIA (see [17] and references herein). 
Residues Trp-214, Lys-199 and Tyr-411 have been implicated 
in the binding process, and each is located strategically in the 
IIA or IIIA hydrophobic pockets [20,21]. 
In subdomain IIA (Fig. IB) the ligands with a carboxylate 
group interact with charged Arg-257, Arg-222 and Lys-199 
[17]. The hydrophobic residues forming the pocket are: Leu-
203, Phe-211, Trp-214, Ala-215, Leu-219, Phe-223, Leu-234, 
Val-235, Leu-238, Val-241, Leu-260, Ala-261, Ile-264, Ile-271, 
Leu-275 and Ile-290. These hydrophobic residues form a focal 
point around Lys-199 and His-242 [17]. The principle hydro-
phobic residues in IIIA are Pro-384, Leu-387, Ile-388, Phe-
395, Leu-407, Val-415, Val-418, Leu-423, Val-426, Leu-430, 
Val-433, Leu-453, Val-456, Leu-457, Leu-460, Val-473 and 
Phe-488. These residues form a focal point around Tyr-411 
and Arg-410 [17]. 
Three key hydrophobic residues of the IIA domain of HSA 
do not have their counterparts in BSA. Leu-203, Phe-211, and 
Ala-215 of HSA are replaced by Ile-203, Leu-211 and Ser-215 
in BSA (Fig. IB). Moreover, 'a focal point' of domain IIA 
structural organisation, Lys-199 of HSA, is replaced by Arg-
199 when in BSA. Lys-199 together with Arg-222 was shown 
to play a key role in the process of carboxylate binding by 
HSA [17]. Both these residues are replaced (by Arg-199 and 
Lys-222) on progressing from HSA to BSA (Fig. IB). 
The residues forming the IIIA domain are totally (with only 
one minor exception: Val-456 of HSA is changed by Ile-456 in 
BSA) homologous with those forming the corresponding do-
main of BSA (Fig. IB). It is difficult to imagine that the 
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replacement of one hydrophobic residue by another (and also 
hydrophobic) may eliminate the interactions between the C P T 
and the BSA. 
Finally, domain IIA of HSA is supposed to be a principle 
site of C P T binding. The residues Leu-203, Phe-211, and Ala-
215 of HSA may undergo direct hydrophobic interactions 
with the C P T chromophore whereas the positively charged 
groups of Lys-199 and Arg-222 may stabilise the complex 
by direct interaction with the carbonyl group of ring D of 
the lactone form and with the carbonyl group of ring D and 
the carboxyl of hydrolysed ring E of the carboxylate form of 
CPT. 
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